United Kingdom · Question · Written question
UIN 53604
Medicines and Healthcare products Regulatory Agency: Costs
Original
Introduced
20 May 2025
Last action
2 June 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Healthcare
Source updated
2 June 2025
Summary
To ask the Secretary of State for Health and Social Care, with reference to the impact assessment for the Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025, published on 25 February 2025, whether the calculations used to estim
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
20 May 2025
Written question
To ask the Secretary of State for Health and Social Care, with reference to the impact assessment for the Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025, published on 25 February 2025, whether the calculations used to estim
Source: Commons
2 June 2025
Answer
The Medicines and Healthcare products Regulatory Agency (MHRA) is subject to the increase in employer National Insurance contributions announced in the 2024 Autumn Budget. For their current fees uplift, the MHRA modelled their future costs, using historic...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-05-20/53604
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1804536
- uk · wq-1804536 · source updated 2 June 2025